Skip to Content

Clinical Trials

Many of our physicians are participating in clinical studies or serving as principal investigators. These studies research questions with significant implications for patients. Patients who participate in clinical trials receive access to the current standard of care, as well as the potential to be treated with a new innovative therapy even before it becomes widely available. Other studies seek to improve quality of life for patients.

INSITE: Investigation of Sacroiliac Fusion Treatment

Investigation of Sacroiliac Fusion Treatment is a multicenter, prospective, randomized trial.

The purpose of this study is to compare outcomes when patients with degenerative sacroiliitis (arthritis of the SI joint) and or sacroiliac disruption (abnormal separation or tearing of the sacroiliac joint)undergo either SI joint fusion with the iFuse Implant System or undergo specific, targeted non-surgical treatment of the SI joint.

If you would like to learn more about this trial please follow the link below or contact Tina Fortney RN CCRC @ 425-688-5407 or tina.fortney@overlakehospital.org.

http://www.lowbackpainhelp.com/

Clinical Trial Categories

4 Trials Cardiology
3 Trials Neurosurgery
3 Trials Oncology
1 Trial Plastic Surgery
2 Trials Surgical
1 Trial Vascular

Potential Benefits

  • Possibility of early access to innovative therapies that may be better than current treatment options.
  • Study-related healthcare provided by a team of experts, including top physicians and researchers, along with nurses, statisticians and social workers.
  • Enhanced patient monitoring and individualized care.
  • Increased understanding of the disease and its treatment.

Potential Risks/Disadvantages

  • Possibility of unknown side effects.
  • New drug/treatment may be ineffective or less effective than current options.
  • Greater time commitment to treatment.

Who qualifies?

Not everyone with a specific disease or condition is eligible. Type and extent of disease, age and health status can determine your eligibility. But if early results of an experimental treatment are encouraging, eligibility is usually broadened.

If you are interested in any of the listed protocols at Overlake, you may contact Tina Fortney, BSN certified clinical research coordinator at 425-688-5407.

Additional Resources